Total Payments
$3,376
2024 Payments
$125.00
Companies
9
Transactions
183
Payment Breakdown by Category
Food & Beverage$3,260 (96.6%)
Education$115.86 (3.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,260 | 171 | 96.6% |
| Education | $115.86 | 12 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $961.79 | 43 | $0 (2024) |
| Alkermes, Inc. | $825.61 | 36 | $0 (2022) |
| Allergan Inc. | $392.04 | 19 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $337.96 | 28 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $330.92 | 24 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $302.71 | 18 | $0 (2019) |
| Lundbeck LLC | $172.97 | 11 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $38.83 | 3 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $13.14 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.00 | 1 | Otsuka America Pharmaceutical, Inc. ($125.00) |
| 2022 | $101.20 | 1 | Alkermes, Inc. ($101.20) |
| 2020 | $155.10 | 3 | Alkermes, Inc. ($125.00) |
| 2019 | $1,250 | 92 | Alkermes, Inc. ($346.81) |
| 2018 | $1,051 | 46 | Otsuka America Pharmaceutical, Inc. ($394.46) |
| 2017 | $693.40 | 40 | Otsuka America Pharmaceutical, Inc. ($244.54) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/16/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/16/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $101.20 | General |
| Category: CNS | ||||||
| 08/11/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: CNS | ||||||
| 08/11/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: CNS | ||||||
| 02/12/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 12/11/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: CNS | ||||||
| 11/01/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: CNS | ||||||
| 10/31/2019 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.79 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: CNS | ||||||
| 10/29/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: CNS | ||||||
| 10/24/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: CNS | ||||||
| 10/24/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: CNS | ||||||
| 10/11/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: CNS | ||||||
| 10/09/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $1.01 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $0.31 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: NEUROLOGY | ||||||
| 10/02/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, SPRAVATO | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Neuroscience | ||||||
| 10/02/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, SPRAVATO | Food and Beverage | In-kind items and services | $2.54 | General |
| Category: Neuroscience | ||||||
| 10/01/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: CNS | ||||||
| 09/18/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: CNS | ||||||
| 09/12/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Vyvanse (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Central Nervous System (CNS) | ||||||
| 09/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Vyvanse (Drug) | Food and Beverage | In-kind items and services | $3.15 | General |
| Category: Central Nervous System (CNS) | ||||||
| 09/11/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Robert Young, M.D
Dr. Robert Young, M.D is a Psychiatry healthcare provider based in Waianae, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003824152.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Young, M.D has received a total of $3,376 in payments from pharmaceutical and medical device companies, with $125.00 received in 2024. These payments were reported across 183 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($3,260).
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location Waianae, HI
- Active Since 08/04/2006
- Last Updated 09/11/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1003824152
Products in Payments
- ABILIFY MAINTENA (Drug) $728.78
- ARISTADA (Drug) $471.81
- REXULTI (Drug) $405.98
- VRAYLAR (Drug) $392.04
- INGREZZA (Drug) $330.92
- LATUDA (Drug) $329.74
- Aristada 441 mg (Drug) $252.60
- INVEGA SUSTENNA (Drug) $188.27
- INVEGA TRINZA (Drug) $112.84
- LYBALVI (Drug) $101.20
- Vyvanse (Drug) $25.27
- Trintellix (Drug) $13.56
- BELSOMRA (Drug) $13.14
- BROVANA (Drug) $8.22
- SPRAVATO (Drug) $1.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.